Science Daily1h
Clinical trial shows positive results for potential treatment to combat a challenging rare disease
Researchers have demonstrated that inebilizumab reduced the risk of symptoms by 87 percent in patients with the rare affliction known as immunoglobulin G4-related disease (IgG4-RD).
Flow Space on MSN1h
Dr. Sara Gottfried Shares Actionable Steps to Help Women With Chronic Illness Improve Overall Well-Being
At the recent Eudēmonia Summit, Dr. Sara Gottfried explained why understanding the root cause of chronic illness is more ...
Dear Doctor: Should older adult, who never had chickenpox, get the shingles vaccine?
DEAR DR. ROACH: A few months ago, you wrote about the benefits of the shingles vaccine. At 63, I’m one of the 1% who has ...
Women with menopause symptoms don't have to suffer, doctors say
"There are heightened PMS symptoms, breast tenderness, bloating, changes in their bleeding patterns, migraine, joint pain, a whole host of symptoms," Dr. Noble explained. Studies show that many ...